CLSI H47-A2
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline – Second Edition., H47-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2008
Side Navigation
X
CLSI EP18-A2 (R2018)
Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline, Second Edition; EP18P3
standard by Clinical and Laboratory Standards Institute, 11/01/2009
CLSI M54-A
Principles and Procedures for Detection of Fungi in Clinical Specimens – Direct Examination and Culture; Approved Guideline, M54A
standard by Clinical and Laboratory Standards Institute, 10/01/2012
CLSI EP10-A3-AMD
Preliminary Evaluation of Quantitative Clinical Laboratory Methods, Approved Guideline – Third Edition, EP10A3AMDE
standard by Clinical and Laboratory Standards Institute, 05/01/2014
CLSI POCT06
Effects of Different Sample Types on Glucose Measurements, 1st Edition, POCT06Ed1E
standard by Clinical and Laboratory Standards Institute, 05/01/2015
CLSI EP37
Supplemental Tables for Interference Testing in Clinical Chemistry, 1st Edition, EP37Ed1E
standard by Clinical and Laboratory Standards Institute, 04/01/2018
CLSI NBS05-A
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,
CLSI QMS06-A3 (R2018)
Quality Management System: Continual Improvement; Approved Guideline – Third Edition, QMS06A3E
standard by Clinical and Laboratory Standards Institute, 06/01/2011
CLSI M38
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Third Edition, M38Ed3E
standard by Clinical and Laboratory Standards Institute, 11/01/2017
CLSI C59-A
Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline, C59AE
standard by Clinical and Laboratory Standards Institute, 09/19/1997